Identifying Hepatic Steatosis: A Guide for APPs
Hepatic steatosis is one of the earliest detectable manifestations of metabolic dysfunction-associated liver disease. Therefore, identifying hepatic steatosis is an important aspect of contemporary metabolic liver care. APPs are often the first point of contact for clinical encounters with patients with obesity, type 2 diabetes, dyslipidemia, and hypertension, and clinical hepatic steatosis. APPs are required to understand the criteria for screening, the imaging techniques and alternative models of clinical best practice in order to ensure the accurate screening and appropriate follow up for clinical hepatic steatosis. APPs are able to identify areas for improvement in their clinical practice related to hepatic steatosis through expert-led education and clinical tools on the MASLD Community Network and improve their clinical practice on the evidence-based management of hepatic steatosis.
Strengthening the Detection of Hepatic Steatosis: APPs Guide is a comprehensive resource for all aspects of detecting hepatic fat, including the appropriate use of imaging, non-invasive risk stratification tools, and clinical best practices. Early detection is imperative to allow APPs to act prior to the onset of associated inflammation and fibrosis, resulting in better long-term outcomes in liver and metabolic health. Using the coaching and educational tools from the MASLD Community Network, advanced practice providers can understand the importance of identifying and streaming patients into organized, proactive metabolic liver care programs.
